Ms Jacqueline Noonan
Jacqueline Noonan’s love of science and innovation has led her to contributing to developing more effective treatments for those with Alzheimer’s disease.
With a strong passion for neuroscience, Jacqueline is currently completing her PhD investigating dysfunctional connectivity in cognitive decline associated with Alzheimer’s disease. Under the guidance of Professor Kate Hoy, Jacqueline hopes to become a research fellow and progress to the next stage of her career.
I’ve got so many questions, and I hope to be a part of finding those answers. For myself and for others.
Jacqueline completed an internship program at Deakin University, within the cognitive neuroscience unit, where she was her first “taste” of transcranial magnetic stimulation (TMS). TMS is a safe and painless electrical stimulation technique, which uses magnetic pulses to alter brain activity. Professor Kate Hoy has developed a treatment program using TMS to improve brain function in people with Alzheimer’s disease.
“I’ve been very fortunate and impressed by a lot of the people that I’ve been working with, particularly Kate. I think she’s incredible”
As part of the Cognitive Therapeutics team, Jaqueline takes part in analysing data from the Bionics Institute’s TRAM trial, which focusses on mild to moderate Alzheimer’s disease. Her sub-study examines brain connectivity in individuals with Mild Cognitive Impairment (MCI) and healthy older adults to further explore cognitive decline.
My goal is to help slow or even prevent cognitive decline in individuals with Alzheimer’s disease, improving their quality of life and giving hope to both patients and their families.
